logo

Obalon Therapeutics Inc (OBLN)



Trade OBLN now with
  Date
  Headline
6/19/2020 6:24:06 AM Obalon Therapeutics Q1 Net Loss $5.3 Mln Or $0.68/Shr Vs Loss $8.3 Mln Or $3.59/Shr Last Year
12/18/2019 8:37:28 AM Obalon Therapeutics Enters One-year Agreement With Al Danah Medical Co.
12/10/2019 1:33:37 PM Spindletop Capital Management Promotes Kelly Huang To Managing Director
10/22/2019 8:21:06 AM Obalon Announces First Patient Treatments At First Company-Owned Center For Weight Loss
10/3/2019 9:12:05 AM Obalon Therapeutics Reports Repayment Of All Long-Term Debt
8/2/2019 8:58:37 AM Obalon Therapeutics Reports Pricing Of $15 Mln Public Offering
7/16/2019 8:37:23 AM Obalon Therapeutics Obtains Two New U.S. Patents Covering Its Proprietary Intragastric Balloon System
6/10/2019 8:38:20 AM Obalon Therapeutics Appoints Bob MacDonald Chief Retail Officer
6/10/2019 8:35:41 AM Obalon Therapeutics Appoints Bob MacDonald As Chief Retail Officer
1/2/2019 8:46:49 AM Obalon Therapeutics Promotes Kelly Huang To CEO
12/21/2018 9:07:38 AM Obalon Announces FDA Approval Of Obalon Navigation System
11/2/2018 8:09:12 AM Obalon Therapeutics Q3 Net Loss $6.7 Mln, Revenue $3.0 Mln
10/9/2018 9:03:29 AM Obalon Therapeutics Appoints Daina Schmidt To VP, Marketing